Literature DB >> 8843898

Mechanism of the hypotensive action of anandamide in anesthetized rats.

K Varga1, K D Lake, D Huangfu, P G Guyenet, G Kunos.   

Abstract

We studied the effects of the endogenous cannabinoid ligand anandamide on blood pressure, single unit activity of barosensitive neurons in the rostral ventrolateral medulla, and postganglionic splanchnic sympathetic nerve discharge in urethane-anesthetized rats. In rats with an intact baroreflex, an intravenous bolus of 4 mg/kg anandamide caused a triphasic blood pressure response: transient hypotension, followed by a brief pressor and more prolonged depressor phase. Anandamide evoked a "primary" increase in neuronal firing coincident with its pressor effect and a "secondary," baroreflex-mediated rise coincident with its depressor effect at both sites. Pretreatment of rats with phentolamine or trimethaphan did not inhibit either the pressor response or the primary increase in splanchnic nerve discharge elicited by anandamide. In barodenervated rats, electrical stimulation of the rostral ventrolateral medulla increased blood pressure and splanchnic nerve discharge. Anandamide treatment blunted the rise in blood pressure without affecting the increase in splanchnic nerve discharge. Anandamide did not affect the rise in blood pressure in response to an intravenous bolus dose of phenylephrine. The results indicate that (1) the brief pressor response to anandamide is not sympathetically mediated, and (2) the prolonged hypotensive response to anandamide is not initiated in the central nervous system, in ganglia, or at postsynaptic adrenergic receptors but is due to a presynaptic action that inhibits norepinephrine release from sympathetic nerve terminals in the heart and vasculature.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8843898     DOI: 10.1161/01.hyp.28.4.682

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  51 in total

Review 1.  The complexities of the cardiovascular actions of cannabinoids.

Authors:  Michael D Randall; David A Kendall; Saoirse O'Sullivan
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

Review 2.  Triphasic blood pressure responses to cannabinoids: do we understand the mechanism?

Authors:  Barbara Malinowska; Marta Baranowska-Kuczko; Eberhard Schlicker
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

3.  A case of ischemic stroke after bonzai: syntetic cannabinoid from Turkey.

Authors:  Yildiz Degirmenci; Hulusi Kececi; Nurten Olmez
Journal:  Neurol Sci       Date:  2015-10-14       Impact factor: 3.307

4.  Central and peripheral components of the pressor effect of anandamide in urethane-anaesthetized rats.

Authors:  Grzegorz Kwolek; Agnieszka Zakrzeska; Eberhard Schlicker; Manfred Göthert; Grzegorz Godlewski; Barbara Malinowska
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

5.  Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects.

Authors:  Grzegorz Godlewski; Shakiru O Alapafuja; Sándor Bátkai; Spyros P Nikas; Resat Cinar; László Offertáler; Douglas Osei-Hyiaman; Jie Liu; Bani Mukhopadhyay; Judith Harvey-White; Joseph Tam; Karel Pacak; Jacqueline L Blankman; Benjamin F Cravatt; Alexandros Makriyannis; George Kunos
Journal:  Chem Biol       Date:  2010-11-24

Review 6.  Endocannabinoids and cardiac contractile function: pathophysiological implications.

Authors:  Sándor Bátkai; Pál Pacher
Journal:  Pharmacol Res       Date:  2009-08       Impact factor: 7.658

7.  Vascular effects of anandamide and N-acylvanillylamines in the human forearm and skin microcirculation.

Authors:  Pouya Movahed; Vladimir Evilevitch; Tomas L G Andersson; Bo A G Jönsson; Per Wollmer; Peter M Zygmunt; Edward D Högestätt
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

8.  In vivo effects of CB2 receptor-selective cannabinoids on the vasculature of normal and arthritic rat knee joints.

Authors:  J J McDougall; V Yu; J Thomson
Journal:  Br J Pharmacol       Date:  2007-11-05       Impact factor: 8.739

9.  The CB1 antagonist, SR141716A, is protective in permanent photothrombotic cerebral ischemia.

Authors:  Zachary Wilmer Reichenbach; Hongbo Li; Sara Jane Ward; Ronald F Tuma
Journal:  Neurosci Lett       Date:  2016-07-21       Impact factor: 3.046

Review 10.  The emerging role of the endocannabinoid system in cardiovascular disease.

Authors:  Pál Pacher; Sabine Steffens
Journal:  Semin Immunopathol       Date:  2009-04-09       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.